Acrongenomics Inc. (OTCBB:AGNM) is pleased to announce that it has entered into a new era of applications by troubleshooting conventional PCR problems with its first application, the Neo-EpCAM(TM) Cancer detection kit as a result of its ongoing Nano-JETA(TM) platform, which combines nanotechnology with molecular biology and applies in molecular diagnostics, enzyme reactions (with use in many aspects of the clinical health care systems, including universal ELISA Detection Systems) and Real Time PCR. Our main scope is to create revolutionary products that meet all market needs.
